BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gatto L, Nannini M, Saponara M, Di Scioscio V, Beltramo G, Frezza GP, Ercolani G, Pinna AD, Astolfi A, Urbini M, Brandi G, Biasco G, Pantaleo MA. Radiotherapy in the management of gist: state of the art and new potential scenarios. Clin Sarcoma Res 2017;7:1. [PMID: 28078078 DOI: 10.1186/s13569-016-0065-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Jiang T, Mu M, Zhao Z, Yin X, Cai Z, Zhang B, Yin Y. Radiotherapy in the Management of Gastrointestinal Stromal Tumors: A Systematic Review. Cancers 2022;14:3169. [DOI: 10.3390/cancers14133169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Klug LR, Khosroyani HM, Kent JD, Heinrich MC. New treatment strategies for advanced-stage gastrointestinal stromal tumours. Nat Rev Clin Oncol 2022. [PMID: 35217782 DOI: 10.1038/s41571-022-00606-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
3 Wei J, Zhong J, Chen Z, Huang Q, Wei F, Wang Q, Cao J. Survival outcome of local vs. radical excision in rectal gastrointestinal stromal tumor: a SEER database analysis. BMC Surg 2022;22. [DOI: 10.1186/s12893-022-01485-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lu Z, Li R, Cao X, Liu C, Sun Z, Shi X, Shao W, Zheng Y, Song J. Assessment of Systemic Inflammation and Nutritional Indicators in Predicting Recurrence-Free Survival After Surgical Resection of Gastrointestinal Stromal Tumors. Front Oncol 2021;11:710191. [PMID: 34381731 DOI: 10.3389/fonc.2021.710191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Tsai TH, Chen YJ, Wang LY, Hsieh CH. Effect of Synchronous Versus Sequential Regimens on the Pharmacokinetics and Biodistribution of Regorafenib with Irradiation. Pharmaceutics 2021;13:386. [PMID: 33805831 DOI: 10.3390/pharmaceutics13030386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Li L, Yi X, Cui H, Zhao X, Dang J, Jiang Q, Li Y. Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Drug-Resistant Gastrointestinal Stromal Tumors: A Feasibility Study. Front Oncol 2020;10:545892. [PMID: 33330024 DOI: 10.3389/fonc.2020.545892] [Reference Citation Analysis]
7 Ramaswamy A, Chaudhari V, Bhargava P, Bhandare M, Kumar R, Shrikhande SV, Ostwal V. Gastrointestinal Stromal Tumor – An Overview. Indian Journal of Medical and Paediatric Oncology 2020;41:809-818. [DOI: 10.4103/ijmpo.ijmpo_45_20] [Reference Citation Analysis]
8 Callegaro D, Raut CP, Keung EZ, Kim T, Le Pechoux C, Martin-Broto J, Gronchi A, Swallow C, Gladdy R. Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID-19 pandemic: A guide for surgical oncologists. J Surg Oncol 2021;123:12-23. [PMID: 33022754 DOI: 10.1002/jso.26246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Onyema MC, Drakou EE, Giovos G, Leca BM, Kosmas C, Ganguly R, Murthy N, Grossman AB, Randeva HS, Dimitriadis GK. Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour. Endocrine and Metabolic Science 2020;1:100047. [DOI: 10.1016/j.endmts.2020.100047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ijzerman NS, Mohammadi M, Tzanis D, Gelderblom H, Fiore M, Fumagalli E, Rutkowski P, Bylina E, Zavrakidis I, Steeghs N, Bonenkamp HJ, van Etten B, Grünhagen DJ, Rasheed S, Tekkis P, Honoré C, van Houdt W, van der Hage J, Bonvalot S, Schrage Y, Smith M. Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour (GIST) in a large European cohort. European Journal of Surgical Oncology 2020;46:1124-30. [DOI: 10.1016/j.ejso.2020.02.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
11 Farag S, Smith MJ, Fotiadis N, Constantinidou A, Jones RL. Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates. Curr Treat Options Oncol 2020;21:55. [PMID: 32462367 DOI: 10.1007/s11864-020-00754-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
12 Yilmaz MT, Gultekin M, Yalcin S, Tuncel M, Gedikoglu G, Yildiz F, Cengiz M. Stereotactic ablative radiotherapy for bone metastasis of gastrointestinal stromal tumor: Case report and review of the literature. Rep Pract Oncol Radiother 2020;25:331-5. [PMID: 32256218 DOI: 10.1016/j.rpor.2020.02.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Callegaro D, Kirsch R, Abdul Razak AR, Quereshy FA, Swallow CJ. Gastrointestinal Stromal Tumor. Surgical Oncology Manual 2020. [DOI: 10.1007/978-3-030-48363-0_12] [Reference Citation Analysis]
14 Yang P, Guo J. Radiotherapy as salvage treatment after failure of tyrosine kinase inhibitors for a patient with advanced gastrointestinal stromal tumor. Journal of Cancer Research and Practice 2018;5:156-60. [DOI: 10.1016/j.jcrpr.2018.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Schrage Y, Hartgrink H, Smith M, Fiore M, Rutkowski P, Tzanis D, Messiou C, Servois V, Bonvalot S, van der Hage J. Surgical management of metastatic gastrointestinal stromal tumour. European Journal of Surgical Oncology 2018;44:1295-300. [DOI: 10.1016/j.ejso.2018.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ozkan EE. Radiotherapy for Gastrointestinal Stromal Tumors. Chin Med J (Engl) 2018;131:235-40. [PMID: 29336374 DOI: 10.4103/0366-6999.222344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
17 Willobee BA, Quiroz HJ, Sussman MS, Thorson CM, Sola JE, Perez EA. Current treatment strategies in pediatric gastrointestinal stromal cell tumor. Transl Gastroenterol Hepatol 2018;3:53. [PMID: 30225387 DOI: 10.21037/tgh.2018.07.09] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kameyama H, Kanda T, Tajima Y, Shimada Y, Ichikawa H, Hanyu T, Ishikawa T, Wakai T. Management of rectal gastrointestinal stromal tumor. Transl Gastroenterol Hepatol 2018;3:8. [PMID: 29552659 DOI: 10.21037/tgh.2018.01.08] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
19 Roberto M, Falcone R, Mazzuca F, Archibugi L, Castaldi N, Botticelli A, Osti MF, Marchetti P. The role of stereotactic body radiation therapy in oligometastatic colorectal cancer: Clinical case report of a long-responder patient treated with regorafenib beyond progression. Medicine (Baltimore) 2017;96:e9023. [PMID: 29310420 DOI: 10.1097/MD.0000000000009023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
20 Loaiza-Bonilla A, Bonilla-Reyes PA. Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy. Cureus 2017;9:e1710. [PMID: 29188154 DOI: 10.7759/cureus.1710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
21 Ramzy L, Nasr M, Metwally AA, Awad GA. Cancer nanotheranostics: A review of the role of conjugated ligands for overexpressed receptors. European Journal of Pharmaceutical Sciences 2017;104:273-92. [DOI: 10.1016/j.ejps.2017.04.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 13.0] [Reference Citation Analysis]